United States Transmyocardial Revascularization Devices Markets 2017-2018: AHA Estimates Approximately 9.8 Million Americans Experience Angina Symptoms

Many patients with severe angina experience inadequate response to pharmacological approaches and require surgical treatment such as PCI with or without stenting, or CABG. Many patients with chronic, severe angina are not candidates for PCI or CABG because of a variety of reasons including failed prior procedures, diffuse coronary artery disease, distal stenosis or extremely small coronary arteries. These patients represent the primary target population for treatment with TMR. Transmyocardial revascularization (TMR) is a surgically performed laser-based heart treatment procedure in which transmural channels are made in the heart muscle. Many scientific experts believe that these procedures encourage new vessel formation, also known as angiogenesis. TMR therapy is approved for patients suffering from chronic or severe angina. The American Heart Association (AHA) estimates that approximately 9.8 million Americans experience angina symptoms. Key Topics Covered:Executive Summary1. Research...

Many patients with severe angina experience inadequate response to pharmacological approaches and require surgical treatment such as PCI with or without stenting, or CABG. Many patients with chronic, severe angina are not candidates for PCI or CABG because of a variety of reasons including failed prior procedures, diffuse coronary artery disease, distal stenosis or extremely small coronary arteries. These patients represent the primary target population for treatment with TMR.

Transmyocardial revascularization (TMR) is a surgically performed laser-based heart treatment procedure in which transmural channels are made in the heart muscle. Many scientific experts believe that these procedures encourage new vessel formation, also known as angiogenesis. TMR therapy is approved for patients suffering from chronic or severe angina. The American Heart Association (AHA) estimates that approximately 9.8 million Americans experience angina symptoms.

Key Topics Covered:

Executive Summary

1. Research Methodology

2. Disease Overview

3. Product Portfolio

4. Transmyocardial Revascularization Device Market

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/research/p2nwln/united_states?w=5

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716